Skip to main content
Premium Trial:

Request an Annual Quote

Affy Stock Slides 6.5 Percent on News of Price Cuts

NEW YORK (GenomeWeb News) - Shares in Affymetrix were down 6.5 percent, or $1.53, at $21.82 in mid-afternoon trading today after the company said yesterday it will cut prices on certain of its genotyping chips.
 
The company said it would reduce the price on its 500K SNP system to $250 and offer the two-chip system as a single array by the end of the year. While the company declined to say how much the system currently costs, it said a 1-million-SNP product, scheduled to be available in early 2007, is expected to sell for around $500.

The Scan

Not as High as Hoped

The Associated Press says initial results from a trial of CureVac's SARS-CoV-2 vaccine suggests low effectiveness in preventing COVID-19.

Finding Freshwater DNA

A new research project plans to use eDNA sampling to analyze freshwater rivers across the world, the Guardian reports.

Rise in Payments

Kaiser Health News investigates the rise of payments made by medical device companies to surgeons that could be in violation of anti-kickback laws.

Nature Papers Present Ginkgo Biloba Genome Assembly, Collection of Polygenic Indexes, More

In Nature this week: a nearly complete Ginkgo biloba genome assembly, polygenic indexes for dozens of phenotypes, and more.